The silencing of GLI2 or cFlip was shown to increase the number of apoptotic cells induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in BCC tissue ex vivo. Here, CFLAR is linked to skin basal cell carcinoma.